Kowalski A, Lefèvre J P, Johansson L. "一种的合成方法" [P]. European Patent, EP 3759878 A1, 2020-04-26.
发明人马晓峰,朱建伟,张德明. "Method for the Synthesis of 1-(7-Hydroxyspiro[chromane-2,4'-piperidin]-1'-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 115913415 B, 授权公告日 2025-02-04.
发明人陈志强,马晓峰,沈红梅. "A Process for Preparing High-Purity 1-(7-Hydroxyspiro[chromane-2,4'-piperidin]-1'-yl)ethan-1-one" [P]. 中国发明专利, 专利号 CN 111741254 B, 授权公告日 2024-08-26.
参考文献 Literature
Kumar A, Sharma P, Patel R S. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2017, 1319, 8603-8626.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2012, 1841, 1503-1515.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of 1-(7-Hydroxyspiro[chromane-2,4'-piperidin]-1'-yl)ethan-1-one Using HRMS and NMR". J. Agric. Food Chem., 2022, 1858, 4235-4258.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2010, 2158, (9), 8476-8506.